Staar Surgical (STAA) FCF Margin (2010 - 2026)
Staar Surgical's (STAA) quarterly FCF Margin came in at 20.52% in Q3 2026, up 8605.0% on a YoY basis from 0.24% in Q3 2025, and up 186.7% quarter-over-quarter from 23.67% in Q2 2026.
Powered by 
Analysis
Staar Surgical (STAA) FCF Margin (2010 - 2026) Analysis & Trends
Staar Surgical (STAA) has reported FCF Margin for 17 consecutive years, with 20.52% the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, FCF Margin rose 8605.0% year-over-year to 20.52%; the trailing twelve-month figure through Jul 2026 stood at 1.99% (up 1750.0% YoY), and the FY2026 full-year result was 16.73%, down 1428.0% from the prior year.
- FCF Margin grew to 20.52% in Q3 2026 per STAA's latest filing, from 23.67% in the prior quarter.
- Across five years, FCF Margin topped out at 37.87% in Q4 2023 and bottomed at 65.53% in Q2 2025.
- Historically, FCF Margin has averaged 4.86% across 5 years, with a median of 9.88% in 2026.
- The sharpest annual moves came in 2025 and 2026: FCF Margin plunged 4871 bps in 2025, then surged 8605 bps in 2026.
- Over 5 years, FCF Margin stood at 5.53% in 2022, then surged by 785 bps to 37.87% in 2023, then sank by 127 bps to 10.38% in 2024, then soared by 118 bps to 1.88% in 2025, then soared by 990 bps to 20.52% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 20.52%, 23.67%, and 9.67% for Q3 2026, Q2 2026, and Q1 2026 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.71 Bn | 174.10 Bn | 7.27 Bn | 15.81% |
| 2 | Intuitive Surgical | 128.01 Bn | 122.80 Bn | 1.96 Bn | 32.79% |
| 3 | Medtronic | 117.20 Bn | 108.38 Bn | 6.34 Bn | 13.22% |
| 4 | Stryker | 104.00 Bn | 100.53 Bn | 4.50 Bn | 16.07% |
| 5 | Boston Scientific | 63.32 Bn | 62.78 Bn | 3.85 Bn | 23.50% |
| 6 | Edwards Lifesciences | 49.95 Bn | 45.70 Bn | 1.35 Bn | 33.60% |
| 7 | Alcon | 32.88 Bn | 31.43 Bn | 1.68 Bn | 21.78% |
| 8 | Dexcom | 32.27 Bn | 30.33 Bn | 830.00 Mn | 14.10% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 18.73% |
| 10 | Staar Surgical | 1.18 Bn | 1.00 Bn | 69.73 Mn | 20.52% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 20.52% |
| Apr 3, 2026 | -23.67% |
| Jan 2, 2026 | -9.67% |
| Sep 26, 2025 | 1.88% |
| Jun 27, 2025 | -65.53% |
| Mar 28, 2025 | -16.91% |
| Dec 27, 2024 | -10.38% |
| Sep 27, 2024 | -2.73% |
| Jun 28, 2024 | -16.82% |
| Mar 29, 2024 | 21.30% |
| Dec 29, 2023 | 37.87% |
| Sep 29, 2023 | -18.88% |
| Jun 30, 2023 | -10.10% |
| Mar 31, 2023 | -10.87% |
| Dec 30, 2022 | -5.53% |
| Sep 30, 2022 | 23.45% |
| Jul 1, 2022 | 9.83% |
| Apr 1, 2022 | -11.31% |
| Dec 31, 2021 | 6.46% |
| Oct 1, 2021 | 32.63% |